Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KET MET study
2009-012658-19Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine, methadone and naloxone in acute pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Relative contribution of NMDA and opioid receptor systems to analgesia, Relative contribution of NMDA and opioid receptor systems to respiratory depression and 2 more. Started May 2009; status: active.
02
Drugs
esketaminemethadonenaloxone
03
Conditions
acute pain
Beyond the preview
Go deeper on 2009-012658-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012658-19.